Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized Study of the Efficacy of Ulipristal Acetate (UPA) 30 mg, Levonorgestrel (LNG) 1.5 mg, and LNG 3.0 mg for Emergency Contraception (EC) in Women With Weight ≥ 80 kg

NCT03537768 is registered in ClinicalTrials.gov with Kimberly Myer as lead sponsor.

NCT NCT03537768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03537768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized Study of the Efficacy of Ulipristal Acetate (UPA) 30 mg, Levonorgestrel (LNG) 1.5 mg, and LNG 3.0 mg for Emergency Contraception (EC) in Women With Weight ≥ 80 kg
Lead sponsor
Kimberly Myer
Phase
Phase 4
Overall status
Terminated
Start date
July 12, 2018
Completion date
April 20, 2022
Enrollment
532 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

contraception